Free Trial

10 Best Small Cap Stocks to Buy Now - 7 of 10

 
 

Achieve Life Sciences (NASDAQ:ACHV)

Consensus Rating
Strong Buy
Rating Score
3.5
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$14.33 (620.3% Upside)

About Achieve Life Sciences

Achieve Life Sciences logoAchieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. More about Achieve Life Sciences
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/14/2024RODMAN&RENSHAWUpgradeStrong-Buy
11/14/2024Rodman & RenshawInitiated CoverageBuy$12.00
9/27/2024Raymond JamesInitiated CoverageStrong-Buy$20.00
8/15/2024OppenheimerReiterated RatingOutperform ➝ Outperform$11.00 ➝ $11.00
5/13/2024OppenheimerLower Price TargetOutperform ➝ Outperform$18.00 ➝ $11.00
4/17/2024JonestradingInitiated CoverageBuy$20.00
4/1/2024OppenheimerReiterated RatingOutperform ➝ Outperform$18.00
3/5/2024Lake Street CapitalLower Price TargetBuy ➝ Buy$19.00 ➝ $11.00
12/12/2023OppenheimerLower Price TargetOutperform ➝ Outperform$21.00 ➝ $18.00
5/31/2023Lake Street CapitalLower Price Target$22.00 ➝ $19.00